Open Call FETOPEN-01-2016-2017: FET-Open Research and Innovation Actions

European CommissionThe successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas. Here agile, risk-friendly and highly interdisciplinary research approaches are needed with collaborations that are open to all sciences and disciplines and that dissolve the traditional boundaries between them. The renewal of ideas is complemented by the renewal of actors taking these new ideas forward. Therefore, this topic encourages the driving role of new high-potential actors in research and innovation, such as excellent young, both female and male, researchers and high-tech SMEs that may become the scientific and industrial leaders of the future.

This topic supports the early stages of research to establish a new technological possibility. Proposals are sought for collaborative research with all of the following characteristics ('FET gatekeepers'):

  • Long-term vision: the research proposed must address a new and radical long-term vision of a science- and technology-enabled future that is far beyond the state of the art and not currently foreseen by technology roadmaps.
  • Breakthrough scientific and technological target: research must target a scientifically ambitious and technologically concrete breakthrough, argued to be a crucial step towards achieving the long-term vision. The plausibility of the proposed breakthrough(s) to be attained within the life-time of the project must be argued in the proposal.
  • Novelty: the research proposed for achieving the breakthrough must be based on cutting-edge knowledge, new ideas and concepts, rather than in the mere application or incremental refinement of existing ones.
  • Foundational: the breakthroughs that are envisaged must be foundational in the sense that, if achieved, they would establish an essential basis for a new kind of technology and its future uses, not currently anticipated.
  • High-risk: the inherently high risk of the research proposed will be reflected in a flexible but effective methodology for exploring alternative directions and options, supported by open and agile research and innovation practices.
  • Interdisciplinary: the proposed collaborations are expected to go beyond 'waterfall' configurations in multi-disciplinary science- and technology research. Instead they should seek new solutions through genuine exchanges, mutual learning, cross-fertilisation and synergistic advances among distant disciplines in order to open unexplored areas of investigation and new directions for joint research.

The Commission considers that proposals requesting a contribution from the EU of up to EUR 3 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Deadline Model: multiple cut-off

Cut-off dates:
11 May 2016 17:00:00
17 January 2017 17:00:00
27 September 2017 17:00:00

Type of action: RIA Research and Innovation action.

For topic conditions, documents and submission service, please visit:
http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/fetopen-01-2016-2017.html

PS: Find your partners or consortia preparing a project proposal
If you are working on Horizon 2020 research project proposals and you would be interested in a SME partner from Germany, please contact us, we are happy to share our experience, expertise and knowledge. If you need help to identify a potential partner with particular competences, facilities or experience, please join and explore our project, (HEALTH IT) SPACE, at www.healthitspace.eu.

Most Popular Now

Artificial Intelligence Solution Improve…

Clinical trials are a critical tool for getting new treatments to people who need them, but research shows that difficulty finding the right volunteer subjects can undermine the effectiveness of...

South West London Pathology Picks CliniS…

One of the first pathology networks in the country, set up to serve more than two million people in south west London, has signed a contract with CliniSys for a...

Call for Tenders: Studies on eHealth, In…

The European Commission is launching a tender for two studies to survey and analyse progress on the digital transformation of the health and care in the EU, in particular with...

AI-based AI-Rad Companion Chest CT Softw…

AI-Rad Companion Chest CT(1), an intelligent software assistant for radiology, was recently awarded the CE mark, which means Siemens Healthineers can start marketing this artificial intelligence (AI)-based software as a...

Spot On for Healthcare Technology Startu…

10 - 12 October 2019, Berlin, Germany. XPOMET Medicinale brings together care providers, patients, and in general stakeholders from all health-related fields and geographic regions. The Festival of Future Medicine and...

Isansys Named as Finalist for OBN's Most…

Isansys Lifecare is proud to announce it has been shortlisted in the Most Transformative Digital Healthcare Company category at the OBN Annual Awards 2019. The award recognises the significant uptake...

7th MEDICA MEDICINE + SPORTS CONFERENCE

18 - 21 November 2019, Düsseldorf, Germany. What lengths do top athletes go to in order to reach peak performances and which findings in the field of professional sports are relevant...

How can We Successfully Converge the Hea…

Opinion Article by Erik Janssen, VP, Innovative Solutions, Neurology, UCB Pharma. The fourth industrial revolution is upon us and fundamentally changing the way we live, work and interact across all industries...

Carestream Health Completes Sale of Heal…

Carestream Healthhas completed the sale of the company's healthcare information solutions business to Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, in 26 of the 38...

Allscripts Listed on Lot One of Health S…

Allscripts has been included on a new list of accredited suppliers of electronic patient records that has been published by NHS England and NHSX. The company is one of just...